Kolon Life Science Inc Capital Reinvestment Ratio
Kolon Life Science Inc capital reinvestment ratio. Kolon Life Science Inc (102940) has a Capital Reinvestment Ratio of 3.12x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩2.58 Billion) in capital expenditures (₩8.05 Billion). Check Kolon Life Science Inc (102940) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kolon Life Science Inc (2011–2016)
Capital reinvestment ratio of Kolon Life Science Inc from 2011 to 2016. This chart tracks Kolon Life Science Inc's Capital Reinvestment Ratio across 5 annual periods. Also explore Kolon Life Science Inc (102940) net asset momentum to track the company's year-over-year net asset growth rate.
Kolon Life Science Inc Capital Reinvestment Ratio by Year (2011–2016)
Kolon Life Science Inc capital reinvestment ratio by year from 2011 to 2016. For the full cash flow conversion analysis, see 102940 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.57x | ₩28.11 Billion | ₩16.14 Billion | ▼ -21.5% |
| 2015 | 0.73x | ₩20.81 Billion | ₩15.22 Billion | ▼ -41.1% |
| 2014 | 1.24x | ₩12.10 Billion | ₩15.01 Billion | ▼ -52.5% |
| 2012 | 2.61x | ₩23.37 Billion | ₩61.01 Billion | ▲ +10.5% |
| 2011 | 2.36x | ₩11.65 Billion | ₩27.52 Billion | — |